PEGS Boston

August 31 - September 4, 2020
Boston, MA, USA

Representative: Oliver Hill, Ph.D., Vice President Drug Discovery/Lead Optimization

Presentation on September 4, 3:10 pm: "HERA-GITRL: A Unique Hexavalent GITR Agonist for Cancer Immunotherapy"


ESMO Congress 2020

September 18-22, 2020
Madrid, Spain

Representative: Andriy Krendyukov, M.D., VP Medical Affairs


Presentations and Posters from Past Conferences

AACR Virtual Annual Meeting II

June 22-24, 2020

Poster #4460:Novel bispecific molecules combining HERA-CD40L with anti-CEA or with anti-PD-L1 for targeting

Poster #4529: Neutralization of pro-apoptotic CD95L by Asunercept/APG101 does not impair anti-tumor immune responses

Presentation #1076: Hexavalent HERA-CD40L induces a productive T cell-mediated anti-tumor immune response and shows superior activity in comparison to benchmark CD40 agonistic antibodies